The Epilepsy Market, a crucial sector in neurology, is forecasted to soar to $9.5 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.39%. This growth trajectory underscores a robust demand for innovative therapies and enhanced diagnostic tools, particularly in light of the 50 million individuals globally affected by epilepsy. The increasing focus on personalized medicine and...